Brookings June 22, 2020
Rosalie Liccardo Pacula and Bradley D. Stein

EXECUTIVE SUMMARY

The breadth, depth, and dynamic evolution of the opioid crisis have left states exploring a plethora of strategies to reduce the supply, inappropriate use, and harm caused by prescription opioid analgesics and illicit opioids. While considerable research has focused on the impact of various supply strategies and prescribing practices, significant structural changes affecting the treatment of substance use disorder—enabled and advanced by states’ policy decisions—have received far less attention.

In this paper, we discuss three broad strategies states are taking, through a variety of policy levers, to enhance the quality of and access to treatment for opioid use disorder (OUD). The first and most well-known strategy involves increasing insurance coverage and payment for...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, States
5 tips on AI adoption from a frontline physician champion
Physician Compensation Continues To Decline, Despite A Dire Shortage
Can Google Street View data provide heart health insights?
Government policies needed for full interoperability in senior care, experts argue
US federal agencies must have a chief AI officer under new order

Share This Article